NasdaqCM:TGTXBiotechs
TG Therapeutics Credit Deal And Valuation Gap Catch Investor Attention
TG Therapeutics, ticker NasdaqCM:TGTX, announced a new five year, $750 million senior secured credit facility with Blue Owl Capital.
The agreement is described as non dilutive, meaning it does not involve issuing new equity to raise capital.
The facility includes repayment of prior debt and could expand to as much as $1b in total available financing.
TG Therapeutics focuses on developing and commercializing therapies in the biopharmaceutical space, where access to sizeable, flexible capital...